SB 174
Creates a voluntary replacement alternative program for children's vaccines that do not contain human DNA content
LR Number:
Last Action:
1/11/2017 - Second Read and Referred S Seniors, Families and Children Committee
Journal Page:
Calendar Position:
Effective Date:
August 28, 2017

Current Bill Summary

SB 174 - Beginning June 1, 2019, the Missouri Department of Health and Senior Services shall not mandate the public clinic use of those children's vaccines containing human deoxyribonucleic acid (DNA), including those vaccines for such diseases as measles, mumps and rubella, varicella, and hepatitis A. Instead, the Department shall develop a voluntary replacement alternative program, which shall include, at the earliest date of availability, replacement vaccines that have been approved by the Centers for Disease Control (CDC) and the Federal Drug Administration (FDA), and which contain no human DNA content.

In the fiscal year prior to the inclusion of any such replacement vaccines in the voluntary replacement alternative program, the Department shall include in its annual budget request details for a state-wide registry for children enrolled in the program, a new schedule of delayed and separated vaccines, a periodic biennial individual screening survey with actual examination of those children with health or functional changes as noted by parents, a waiver of state liability for the replacement vaccines, and estimated annual costs of the program's operation for ten years.

The voluntary replacement alternative program shall automatically expire on August 28, 2029, unless reauthorized.

This act is substantially similar to SB 1058 (2016).